Skip to main content

Nourish Shows 68% Six-Month GLP-1 Persistence, Outperforming Industry Benchmarks

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Findings demonstrate strong signal that dietitian-led care improves GLP-1 persistence and supports long-term health outcomes

Despite the promise of GLP-1s as an effective tool for weight loss, patient persistence on the medication is a barrier to long-term outcomes. Today, Nourish, the only dietitian-led metabolic health clinic in the country, released data showing that 68% of Nourish patients remained on GLP-1 therapy at six months, compared to a 46% industry benchmark. Full results are available in Nourish’s new whitepaper: GLP-1 Persistence through Dietitian-Led Care.

The Nourish GLP-1 Companion Care program pairs evidence-based nutrition therapy delivered by registered dietitians with wraparound physician support. Patients follow a structured clinical pathway and receive personalized nutrition support tailored to their individual needs, helping them achieve their treatment goals while mitigating side effects. This integrated approach is designed to maximize the efficacy and durability of GLP-1 treatment.

Nourish’s data demonstrates that embedding nutrition care directly into GLP-1 treatment improves persistence over time, which in turn helps patients build the sustainable habits that support long-term outcomes.

“We find many patients struggle to stay on GLP-1s long enough to see results due to side effects and lack of support,” said Aidan Dewar, co-founder and CEO of Nourish. “When patients receive personalized, dietitian-led care alongside GLP-1s, they’re better able to tolerate the medications, manage side effects, and ultimately build habits that lead to more durable outcomes.”

Nourish supports patients across the full GLP-1 journey:

  • Nutrition-first care for patients not on medication
  • Companion care alongside medication to improve persistence and manage side effects
  • Off-ramp support to sustain outcomes after medication discontinuation

By pairing medication with ongoing nutrition care, Nourish helps patients stay on therapy longer and achieve better long-term outcomes, while enabling health plans and employers to maximize the value of their GLP-1 investment.

To learn more, read the full whitepaper: GLP-1 Persistence through Dietitian-Led Care.

About Nourish

Nourish is tackling America’s healthcare crisis by addressing the root cause of metabolic disease through insurance-covered, AI-powered virtual nutrition care. The company combines personalized visits with registered dietitians (RDs), labs, and an AI-native technology platform to deliver scalable, effective treatment for chronic conditions.

As the only dietitian-led metabolic health clinic in the country, Nourish makes it easy for patients to get matched to an expert provider, access care from home, and improve their health — typically at no cost. Through partnerships with all major insurers, as well as health systems and local providers, Nourish is available to hundreds of millions of patients across all 50 states. Nourish is actively hiring across clinical and business roles — learn more at usenourish.com.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  241.70
+3.36 (1.41%)
AAPL  294.38
+5.02 (1.73%)
AMD  540.88
-40.03 (-6.89%)
BAC  58.36
+1.38 (2.42%)
GOOG  357.89
+4.56 (1.29%)
META  612.91
+49.62 (8.81%)
MSFT  384.28
+11.26 (3.02%)
NVDA  197.58
-2.51 (-1.25%)
ORCL  142.50
-4.05 (-2.76%)
TSLA  425.30
+4.70 (1.12%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.